Abstract Number: 002 • 2026 Pediatric Rheumatology Symposium
Assessing Juvenile Idiopathic Arthritis Healthcare Costs to Advance Value-Based Care
Background/Purpose: Despite treatment advances and continued quality improvement efforts, outcomes for our patients with juvenile idiopathic arthritis (JIA) remain suboptimal. To address this challenge, we…Abstract Number: 003 • 2026 Pediatric Rheumatology Symposium
Dysregulated Macrophage–Fibroblast Crosstalk Identified by Single-Cell RNA-seq in Juvenile Systemic Scleroderma Skin
Background/Purpose: Juvenile systemic scleroderma (jSSc) is a rare autoimmune disease characterized by progressive fibrosis and vascular dysfunction. Although jSSc shares important clinical features with adult…Abstract Number: 013 • 2026 Pediatric Rheumatology Symposium
Kikuchi-Fujimoto’s Disease in Systemic Lupus Erythematosus: Single-center Experience
Background/Purpose: Kikuchi-Fujimoto disease (KD), also known as histiocytic necrotizing lymphadenitis, is a self-limited disease of unknown etiology. An association between KD and systemic lupus erythematosus…Abstract Number: 008 • 2026 Pediatric Rheumatology Symposium
Body Mass Index, Neighborhood Opportunity, and Outcomes of Childhood-Onset Lupus
Background/Purpose: The interplay between body mass index (BMI) and disease outcomes in childhood-onset systemic lupus erythematosus (cSLE) has not been characterized. Neighborhood factors drive health…Abstract Number: 005 • 2026 Pediatric Rheumatology Symposium
Magnetic Resonance Enterography Detected Sacroiliitis in Pediatric Crohn’s Disease: A Retrospective Cohort Study
Background/Purpose: Musculoskeletal (MSK) manifestations are amongst the most common extraintestinal manifestations (EIMs) in pediatric Crohn’s disease (CD). MSK EIMs contribute to reduced quality of life…Abstract Number: 006 • 2026 Pediatric Rheumatology Symposium
Age Matters: Clinical Profile and IVIG Responsiveness in infants with Kawasaki Disease. A multicentric retrospective analysis of 36 patients from North India
Background/Purpose: Kawasaki disease (KD) is a systemic medium vessel vasculitis that is predominantly a clinical diagnosis as defined by the American Heart Association (AHA). KD…Abstract Number: 001 • 2026 Pediatric Rheumatology Symposium
Longitudinal Cardiovascular Profiles of Youth with Childhood-onset Systemic Lupus Erythematosus
Background/Purpose: The cumulative impact of childhood-onset systemic lupus erythematosus (cSLE) on cardiovascular damage begins at disease onset. We sought to characterize longitudinal cardiovascular profiles of…Abstract Number: 007 • 2026 Pediatric Rheumatology Symposium
Subtle Signs, Severe Consequences: Clinical profile of infants with giant coronary aneurysms compared to those with normal coronaries. A multicentric retrospective analysis of infants with Kawasaki disease
Background/Purpose: Kawasaki disease (KD) is a systemic medium vessel vasculitis that is predominantly a clinical diagnosis as defined by the American Heart Association (AHA). KD…Abstract Number: 014 • 2026 Pediatric Rheumatology Symposium
Bone Microarchitecture Impairment in Juvenile Systemic Lupus Erythematosus Patients: A Comparative Study
Background/Purpose: Juvenile Systemic Lupus Erythematosus (jSLE) is a multisystem inflammatory disease frequently associated with bone mass loss. This reduction can be assessed through bone mineral…Abstract Number: 011 • 2026 Pediatric Rheumatology Symposium
Lung Transplant for Pediatric Dermatomyositis Patients with Interstitial Lung Disease: A Single-Center Experience
Background/Purpose: Interstitial lung disease (ILD) is a feared complication of several pediatric rheumatic diseases, particularly dermatomyositis. Lung transplant is often considered as a last resort in these patients, which can lead to delayed transplant assessment…Abstract Number: 009 • 2026 Pediatric Rheumatology Symposium
Functional Lumen Imaging Probe (FLIP) for the Assessment of Esophageal Involvement in Juvenile Systemic Sclerosis: Characteristics and Clinical Utility
Background/Purpose: Juvenile systemic sclerosis (jSSc) is a rare autoimmune and fibrosing disease associated with significant morbidity and mortality. Gastrointestinal involvement is common in jSSc, with…Abstract Number: 012 • 2026 Pediatric Rheumatology Symposium
Prevalence and Impact of Adverse Childhood Experiences in Pediatric Systemic Lupus Erythematosus
Background/Purpose: Adverse childhood experiences (ACEs) have been linked to incident childhood-onset SLE (cSLE) and poorer patient-reported outcomes, raising the possibility that early-life stress may contribute…Abstract Number: 010 • 2026 Pediatric Rheumatology Symposium
Efficacy and Safety of Emapalumab in Patients with Macrophage Activation Syndrome (MAS) in Systemic Lupus Erythematosus (SLE)
Background/Purpose: MAS is a life-threatening complication of SLE, characterized by interferon-gamma (IFNg)-driven macrophage activation and systemic hyperinflammation. There is substantial preclinical evidence of IFNg having…Abstract Number: 015 • 2026 Pediatric Rheumatology Symposium
Obinutuzumab Induces Histologic Remission And Deep Kidney Parenchymal B-Cell Depletion In Patients With Lupus Nephritis: Exploratory Analyses From The REGENCY Trial
Background/Purpose: The REGENCY trial (NCT04221477) demonstrated superiority of obinutuzumab (OBI) plus standard therapy (+ST) vs placebo (PBO) +ST in achieving complete renal response (CRR) at…Abstract Number: 004 • 2026 Pediatric Rheumatology Symposium
Barriers and Facilitators to Teratogenicity Knowledge and Application among Adolescents and Young Adults with Rheumatic Disease
Background/Purpose: Prior studies demonstrate low levels of teratogenicity knowledge among adolescents and young adults (AYAs) with rheumatic disease. This study sought to describe barriers and…
- 1
- 2
- 3
- …
- 2616
- Next Page »